•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.CROSS TIMBERS ROYALTY TRUST DECLARES AUGUST CASH DISTRIBUTION
CROSS TIMBERS ROYALTY TRUST DECLARES JULY CASH DISTRIBUTION
REGENXBIO Presents Positive Long-Term Data for Surabgene Lomparvovec in Wet AMD and Diabetic Retinopathy at American Society of Retina Specialists Annual Meeting
CROSS TIMBERS ROYALTY TRUST DECLARES JUNE CASH DISTRIBUTION
FDA Grants Breakthrough Therapy Designation for Calderasib (MK-1084), an Investigational KRAS G12C Inhibitor, for Certain Patients with Newly Diagnosed Metastatic KRAS G12C-Mutant Non-Small Cell Lung
IMFINZI® (durvalumab) approved in the US in first and only immunotherapy combination for patients with BCG-naïve, high-risk non-muscle-invasive bladder cancer
CROSS TIMBERS ROYALTY TRUST DECLARES MAY CASH DISTRIBUTION
The Iran War Sent Oil Above $100. These 3 Royalty Trusts Are Quietly Paying Double Digit Yields Because of It
Innate Pharma Reports First Quarter 2026 Business Update and Financial Results
CT Real Estate Investment Trust (CRT.UN:CA) Shareholder/Analyst Call Prepared Remarks Transcript
CT Real Estate Investment Trust (CRT.UN:CA) Q1 2026 Earnings Call Transcript
CROSS TIMBERS ROYALTY TRUST DECLARES APRIL CASH DISTRIBUTION
Cross Timbers Royalty Trust (NYSE:CRT) Major Shareholder Eric Oliver Buys 3,159 Shares of Stock
Insider Buying: Cross Timbers Royalty Trust (NYSE:CRT) Major Shareholder Acquires 26,134 Shares of Stock
CROSS TIMBERS ROYALTY TRUSTDECLARES MARCH CASH DISTRIBUTION
CT REIT: Expect More Dividend Increases
Autonomix Medical Selected for Best Innovation Competition at CRT 2026
Autonomix Medical Selected as Top Abstract at CRT 2026 and Selected for Podium Presentation of Clinical Feasibility and Outcomes of Novel Technique for Transvascular Peripheral RF Nerve Neurolysis
Orchestra BioMed Announces Presentations Highlighting AVIM Therapy Potential Impact on Hypertensive Heart Disease and Heart Failure at THT and CRT
CT Real Estate Investment Trust (CRT.UN:CA) Q4 2025 Earnings Call Transcript